Loading insider details...
Beta
Latest Form 4 (Jan 23, 2026): Disposition to Issuer of 10 ATXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 10 | n/a |
| Mar 25, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 225,000 | n/a |
| Feb 12, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 175,000 | n/a |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 80,000 | n/a |
| Mar 4, 2022 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 55,000 | n/a |
| Nov 23, 2021 | Astria Therapeutics, Inc. (ATXS) | Purchase | 100 | $669.50 |
| Jun 2, 2021 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 600,000 | n/a |
| Feb 14, 2020 | CATABASIS PHARMACEUTICALS INC (CATB) | Grant/Award | 35,000 | n/a |